awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36368035-2FBAE253-15AB-4927-9454-649A84897134
Q36368035-2FBAE253-15AB-4927-9454-649A84897134
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36368035-2FBAE253-15AB-4927-9454-649A84897134
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide
P2860
Q36368035-2FBAE253-15AB-4927-9454-649A84897134
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36368035-2FBAE253-15AB-4927-9454-649A84897134
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b60d1a243a6bf41d7496d7e28209aaea2b3de7f2
P2860
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.